← Mechanisms of action
CLDN6
SINGLE PROTEINHomo sapiens
Linked proteins
Drugs acting on this target (18)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| ctim-76 | Binding agent | experimental | mAb | CLDN6 binding agent |
| cldn6 rna-lpx | Immunity, active | experimental | Vaccine | CLDN6 immunity, active |
| bnt142 | Immunity, passive | experimental | Vaccine | CLDN6 immunity, passive |
| claudin6 targeting car-nk cells | Immunity, passive | experimental | Cell therapy | CLDN6 immunity, passive |
| cldn6 car-t | Immunity, passive | experimental | Cell therapy | CLDN6 immunity, passive |
| sail66 | Immunity, passive | experimental | mAb | CLDN6 immunity, passive |
| torl-1-23 | Immunity, passive | experimental | mAb | CLDN6 immunity, passive |
| torl-3-600 | Immunity, passive | experimental | mAb | CLDN6 immunity, passive |
| asp1650 | Inhibitor | experimental | mAb | CLDN6 inhibitor |
| asp1893 | Inhibitor | experimental | mAb | CLDN6 inhibitor |
| at03-65 | Inhibitor | experimental | mAb | CLDN6 inhibitor |
| bgb-b455 | Inhibitor | experimental | mAb | CLDN6 inhibitor |
| imab027 | Inhibitor | experimental | mAb | CLDN6 inhibitor |
| nbl-028 | Inhibitor | experimental | mAb | CLDN6 inhibitor |
| plb-002 | Inhibitor | experimental | mAb | CLDN6 inhibitor |
| qls5132 | Inhibitor | experimental | mAb | CLDN6 inhibitor |
| sc-004 | Inhibitor | experimental | mAb | CLDN6 inhibitor |
| xmab541 | Inhibitor | experimental | mAb | CLDN6 inhibitor |